C13 H17 N9 O3
A1JPC
(2~{R},3~{S},4~{R},5~{R})-2-[[4-(aminomethyl)-1,2,3-triazol-1-yl]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol
Description
Physiochemical properties
Bound structures
Interaction statistics
Ligand-specific databases
We have redesigned this page to enhance your experience. Take an on-page tour.
Synonyms
(2~{R},3~{S},4~{R},5~{R})-2-[[4-(aminomethyl)-1,2,3-triazol-...Show more
Formula
Standard InChI
InChI=1S/C13H17N9O3/c14-1-6-2-21(20-19-6)3-7-9(23)10(24)13(25-7)22-5-18-8-11(15)16-4-17-12(8)22/h2,4-5,7,9-10,13,23-24H,...Show more
Standard InChI Key
NFSJJKJBIKSLTB-QYVSTXNMSA-N
SMILES
c1c(nnn1C[C@@H]2[C@H]([C@H]([C@@H](O2)n3cnc4c3ncnc4N)O)O)CN
Source OpenEye
First observed in
Overall view, and highlighted
scaffolds and fragments ![help icon]()
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
Displayed: 1 / 2